InvestSMART

Aldoro Resources Ltd (ASX: ARN) - Announcements

Current share price for ARN : $0.465 0.035 (8.14%)+

ASX company news and announcements for Aldoro Resources Ltd (ARN) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Aldoro Resources Ltd (ARN) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Aldoro Resources Ltd (ARN), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Aldoro Resources Ltd (ARN)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$110 Latest Kameelburg Assays Up to 10.38% Nb2O5 & 9.89% TREO 20 Jun 2024 10:51AM $0.066 $0.465 risen by 604.55%
$110 Specialist appointed to conduct REE & Niobium Processing 17 Jun 2024 10:43AM $0.066 $0.465 risen by 604.55%
$110 Quarterly Activities/Appendix 5B Cash Flow Report 29 Apr 2024 1:03PM $0.070 $0.465 risen by 564.29%
$110 Latest Kameelburg Assays of up to 6.60% TREO 18 Apr 2024 9:22AM $0.080 $0.465 risen by 481.25%
$110 Final Director's Interest Notice 11 Apr 2024 11:44AM $0.075 $0.465 risen by 520%
$110 Initial Director's Interest Notice 11 Apr 2024 11:36AM $0.075 $0.465 risen by 520%
$110 Corporate Update - Ms Liqun Li Appointed Chairwoman 9 Apr 2024 10:52AM $0.070 $0.465 risen by 564.29%
$110 Final Director's Interest Notice 2 Apr 2024 8:07PM $0.072 $0.465 risen by 545.83%
$110 Kameelburg Carbonatite Geological Exploration Update 2 Apr 2024 9:59AM $0.070 $0.465 risen by 564.29%
$110 Half Yearly Report and Accounts 11 Mar 2024 8:18PM $0.078 $0.465 risen by 496.15%
$110 Further Niobium Assays of up to 8.36% Nb2O5 at Kameelburg 28 Feb 2024 9:36AM $0.105 $0.465 risen by 342.86%
$110 Kameelburg Niobium Investigations Continue 8 Feb 2024 9:45AM $0.093 $0.465 risen by 400%
$110 Quarterly Activities/Appendix 5B Cash Flow Report 25 Jan 2024 6:52PM $0.088 $0.465 risen by 428.41%
$110 Notification of cessation of securities - ARN 2 Jan 2024 8:08PM $0.125 $0.465 risen by 272%
$110 Option Placement Offer - Return of Application Monies 2 Jan 2024 8:07PM $0.125 $0.465 risen by 272%
$110 Kameelburg Niobium Assays reveal up to 9.03% Nb2O5 27 Dec 2023 9:25AM $0.082 $0.465 risen by 467.07%
$110 Passive Seismic Survey Targets Large Pegmatite Feeder 19 Dec 2023 9:32AM $0.083 $0.465 risen by 460.24%
$110 Up To 3.53% TREO For Kameelburg Head Assays 6 Dec 2023 9:25AM $0.083 $0.465 risen by 460.24%
$110 Results of Meeting 9 Nov 2023 2:35PM $0.080 $0.465 risen by 481.25%
$110 Advancing the Wyemandoo Lithium Project 30 Oct 2023 1:04PM $0.099 $0.465 risen by 369.70%
$110 Kameelburg Metallurgical test work program set to commence 19 Oct 2023 9:36AM $0.090 $0.465 risen by 416.67%
$110 Quarterly Activities/Appendix 5B Cash Flow Report 17 Oct 2023 7:25PM $0.090 $0.465 risen by 416.67%
$110 Notification of cessation of securities - ARN 16 Oct 2023 2:23PM $0.093 $0.465 risen by 400%
$110 Notification of cessation of securities - ARN 16 Oct 2023 2:22PM $0.093 $0.465 risen by 400%
$110 Option Placement Offer - Shortfall Notice 16 Oct 2023 12:21PM $0.095 $0.465 risen by 389.47%

251 - 275 of 693 results

Page 11 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.